MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,397,300 | -33.9% | 57,500 | +4.5% | 2.76% | -34.1% |
| Q2 2023 | $12,705,000 | +74.8% | 55,000 | +83.3% | 4.19% | +95.3% |
| Q1 2023 | $7,268,000 | +25.2% | 30,000 | +50.0% | 2.15% | -13.3% |
| Q4 2022 | $5,805,000 | +257.2% | 20,000 | -20.0% | 2.48% | +443.4% |
| Q3 2022 | $1,625,000 | +1508.9% | 25,000 | +2677.8% | 0.46% | +1132.4% |
| Q4 2018 | $101,000 | -96.7% | 900 | -93.7% | 0.04% | -94.3% |
| Q3 2018 | $3,041,000 | -53.7% | 14,200 | -39.6% | 0.65% | -66.6% |
| Q2 2018 | $6,573,000 | – | 23,500 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |